SUBSCRIBE
SUBSCRIBE
News   Business

Verdezyne Seeking Over $10M In Series D To Hit Profitability

January 15, 2009 | 
1 min read
Verdezyne Inc., a developer of organisms used to make biofuels and biochemicals, is out to raise at least $10 million in a Series D round of f inancing, VentureWire has learned.
Startups
MORE ON THIS TOPIC
Business people and concepts vector art exit
Business
Takeda’s long-term R&D head announces exit after major pipeline reorganization
September 10, 2026
 · 
2 min read
 · 
Gabrielle Masson
Vector cartoon illustration of a business team standing at a crossroad with multiple arrows, discussing and choosing the right path toward success and future opportunities.
Drug pricing
Drugmakers cherry pick launch regions as MFN creates ‘policy environment like an earthquake’
September 10, 2026
 · 
4 min read
 · 
Annalee Armstrong
A pay raise signals salary increase, income growth, rising investment profits and earnings, along with career development and wealth management, concept of A jubilant businessman jumping atop a growing stack of money coins
Funding
Encoded raises $275M series F for Dravet syndrome gene therapy
September 10, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of dark room opening into outdoors with sun peeking out
Layoffs
August biopharma layoffs impact just over 500, down 90% year over year
September 10, 2026
 · 
6 min read
 · 
Angela Gabriel